RARE-EVENT ANALYSIS OF CIRCULATING HUMAN DENDRITIC CELL SUBSETS AND THEIR PRESUMPTIVE MOUSE COUNTERPARTS1

Background. Considerable interest has focused recently on murine CD8&agr;− and CD8&agr;+ dendritic cell (DC) subsets, because of their roles in initiating and regulating immune responses. Attention has also centered on their presumed human counterparts, DC1 and DC2, respectively, and their precursors. Identification and quantification of these subsets in the blood may be crucial to understanding and monitoring of their immunologic significance, particularly in humans, where blood may be the only tissue readily or routinely available. Methods. Leukocytes were isolated from anticoagulated human or mouse (C57BL/10J) blood using conventional procedures. Four-color, rare-event, flow cytometric analysis was used to identify DC1 precursors (pDC1; lineage [lin]− CD4+ CD11c+ HLA-DR+) or DC2 precursors (pDC2; lin− CD4+ CD11c− CD123hi [IL-3R&agr;hi] HLA-DR+) in normal humans. In mice, CD8&agr;+ (CD11blo, CD11c+) and CD8&agr;− (CD11bhi, CD11c+) DC subsets were identified both in normal animals and after administration of the potent DC growth factor, fms-like tyrosine kinase 3 ligand (Flt3L). Results. All human subjects examined had discrete populations of pDC1 and pDC2 comprising approximately 0.6% and 0.1% of blood mononuclear cells. CD8&agr;− and CD8&agr;+ DC constituted approximately 0.75% and 0.2%, respectively, of blood mononuclear cells in normal mice, and 12% and 0.5%, respectively, in Flt3L-treated animals. Flt3L administration substantially increased the absolute numbers of circulating CD11c+ DC by approximately 200-fold. Conclusions. In addition to pDC1 and CD8&agr;− DC, pDC2 and CD8&agr;+ DC can be identified in normal human or mouse blood, respectively. Monitoring and isolation or characterization of these cells may provide novel insights into their functional significance in transplantation and other clinical conditions.

[1]  M. Kocova,et al.  Fine quantitation by competitive PCR of circulating donor cells in posttransplant chimeric recipients. , 1994, Transplantation.

[2]  B. Pulendran,et al.  Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. , 1997, Journal of immunology.

[3]  C. Arias,et al.  Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8α− and CD8α+dendritic cells are generated from CD4lowlymphoid-committed precursors , 2000 .

[4]  T. Starzl,et al.  Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony- stimulating factor , 1995, The Journal of experimental medicine.

[5]  W. Burlingham,et al.  Donor dendritic cell persistence in organ allograft recipients in the absence of immunosuppression , 1999, Journal of leukocyte biology.

[6]  Li Wu,et al.  The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells , 1992, The Journal of experimental medicine.

[7]  S. Heimfeld,et al.  Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. , 2000, Blood.

[8]  U. Grohmann,et al.  CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells1 , 2001, The Journal of Immunology.

[9]  S. Specht,et al.  Immature and Mature CD8α+ Dendritic Cells Prolong the Survival of Vascularized Heart Allografts1 , 2002, The Journal of Immunology.

[10]  R. Steinman,et al.  The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies , 1990, The Journal of experimental medicine.

[11]  L. Lefrançois,et al.  Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. , 1995, Journal of immunology.

[12]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[13]  B. Fazekas de St. Groth,et al.  The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. , 1998, Immunology today.

[14]  P. Morris,et al.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.

[15]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[16]  S. Brouard,et al.  Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. , 1998, Blood.

[17]  K. Shortman,et al.  Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny , 1996, The Journal of experimental medicine.

[18]  Freddie H. Fu,et al.  Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. , 1996, Transplantation.

[19]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[20]  E. Kämpgen,et al.  Functions of myeloid and lymphoid dendritic cells. , 2000, Immunology letters.

[21]  L. Lu,et al.  Dendritic cells as regulators of immune reactivity: implications for transplantation. , 1999, Transplantation.

[22]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[23]  Li Wu,et al.  Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population , 1993, Nature.

[24]  S. Lyman,et al.  c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. , 1998, Blood.

[25]  L. Lu,et al.  Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. , 2000, Transplantation.

[26]  Simon C Watkins,et al.  Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients. , 1997, Transplantation.

[27]  T. Starzl,et al.  Weaning of immunosuppression in liver transplant recipients. , 1997, Transplantation.

[28]  R. Maldonado-López,et al.  CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo , 1999, The Journal of experimental medicine.

[29]  G. Marti,et al.  Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations. , 1992, Cytometry.

[30]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[31]  C. Maliszewski,et al.  In vivo generation of human dendritic cell subsets by Flt3 ligand. , 2000, Blood.

[32]  A. Thomson,et al.  Phenotypic and Functional Characterization of Mouse Hepatic CD8α+ Lymphoid-Related Dendritic Cells1 , 2000, The Journal of Immunology.

[33]  B. Pulendran,et al.  Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Banchereau,et al.  Modulating the immune response with dendritic cells and their growth factors. , 2001, Trends in immunology.

[35]  Cañizo,et al.  Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage−  cells , 1999, Clinical and experimental immunology.

[36]  G. Schuler,et al.  Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo , 2000, European journal of immunology.

[37]  J V Giorgi,et al.  Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. , 1998, Cytometry.

[38]  J. Banchereau,et al.  The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand , 1997, The Journal of experimental medicine.

[39]  K. Shortman,et al.  Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. , 1997, Journal of immunology.

[40]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[41]  I. Weissman,et al.  CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. , 1999, Immunity.

[42]  P. Hertzog,et al.  Differential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets1 , 2001, The Journal of Immunology.

[43]  I. Weissman,et al.  Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor , 2000 .

[44]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[45]  K. Shortman,et al.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis , 1996, The Journal of experimental medicine.